Quadrature Capital’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161K Sell
15,104
-60,622
-80% -$666K ﹤0.01% 1816
2026
Q2
$814K Buy
+75,726
New +$618K 0.01% 809
2026
Q1
– Sell
-14,761
Closed -$114K – 1549
2025
Q4
$114K Sell
14,761
-560
-4% -$4.6K ﹤0.01% 1082
2025
Q3
$144K Buy
+15,321
New +$133K ﹤0.01% 836

Other funds holding FENC

Quadrature Capital's FENC Position: Q3 2026 in Review

Quadrature Capital reduced its Fennec Pharmaceuticals (FENC) stake by 80% in Q3 2026, selling an estimated $666K and leaving 15,104 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Quadrature Capital first reported a position in FENC in Q3 2025 and has held it in 4 quarters since. The position peaked at $814K in Q2 2026. 119 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • Quadrature Capital held 15,104 shares of Fennec Pharmaceuticals worth $161K as of Q3 2026.
  • Quadrature Capital sold 60,622 Fennec Pharmaceuticals shares in Q3 2026, an estimated $666K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1816 holding.
  • Quadrature Capital first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Fennec Pharmaceuticals position peaked at $814K in Q2 2026.
  • 119 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.